Biotage AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BIOT.ST research report →
Companywww.biotage.com
Biotage AB (publ) provides separation technologies in the areas of organic and analytical chemistry, biomolecules, and industrial scale up applications. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems and flash system accessories; normal, reversed, and speciality phase cartridges; plasmid purification solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns.
- CEO
- Frederic Vanderhaegen
- IPO
- 2000
- Employees
- 622
- HQ
- Uppsala, SE
Price Chart
Valuation
- Market Cap
- $11.46B
- P/E
- 70.33
- P/S
- 11.85
- P/B
- 2.98
- EV/EBITDA
- 45.13
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 62.25%
- Op Margin
- 16.86%
- Net Margin
- 16.86%
- ROE
- 4.10%
- ROIC
- 3.82%
Growth & Income
- Revenue
- $2.06B · 10.42%
- Net Income
- $284.00M · 15.45%
- EPS
- $3.55 · 6.61%
- Op Income
- $383.00M
- FCF YoY
- -5.43%
Performance & Tape
- 52W High
- $202.20
- 52W Low
- $81.60
- 50D MA
- $142.47
- 200D MA
- $138.61
- Beta
- 0.85
- Avg Volume
- 515.83K
Get TickerSpark's AI analysis on BIOT.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our BIOT.ST Coverage
We haven't published any research on BIOT.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BIOT.ST Report →